These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 16312168

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
    Weiler JM, Nathan RA, Rupp NT, Kalberg CJ, Emmett A, Dorinsky PM.
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
    Berkman N, Avital A, Bardach E, Springer C, Breuer R, Godfrey S.
    Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.
    Ulrik CS, Claudius BK, Tamm M, Harving H, Siersted HC, Backer V, Hellquist B, Dahl R, Høgholm A, Jøhnk IK.
    Clin Respir J; 2009 Jul; 3(3):161-8. PubMed ID: 20298399
    [Abstract] [Full Text] [Related]

  • 27. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
    Camargo CA, Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH, Ortega HG, Ferro TJ.
    J Asthma; 2010 Feb; 47(1):76-82. PubMed ID: 20100025
    [Abstract] [Full Text] [Related]

  • 28. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.
    Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
    [Abstract] [Full Text] [Related]

  • 29. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 30. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma.
    Pérez-de-Llano LA, Carballada F, Castro Añón O, Pizarro M, Golpe R, Baloira A, Vázquez Caruncho M, Boquete M.
    Eur Respir J; 2010 Jun; 35(6):1221-7. PubMed ID: 19996191
    [Abstract] [Full Text] [Related]

  • 31. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG, Lutter R, Jansen HM, van der Zee JS.
    Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
    [Abstract] [Full Text] [Related]

  • 32. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation].
    Wettengel R, Steinkamp G.
    Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652
    [No Abstract] [Full Text] [Related]

  • 33. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 34. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 35. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 Jun; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 36. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T.
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [Abstract] [Full Text] [Related]

  • 37. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
    Boulet LP, Franssen E.
    Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
    [Abstract] [Full Text] [Related]

  • 38. Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combination.
    Cazzola M, Matera MG.
    Chest; 2012 May; 141(5):1134-1136. PubMed ID: 22553257
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacists helping physicians.
    Bowes D.
    CMAJ; 2003 Jan 21; 168(2):151. PubMed ID: 12538538
    [No Abstract] [Full Text] [Related]

  • 40. Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study.
    Bateman ED, Bousquet J, Busse WW, Clark TJ, Gul N, Gibbs M, Pedersen S, GOAL Steering Committee and Investigators.
    Allergy; 2008 Jul 21; 63(7):932-8. PubMed ID: 18588561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.